Not directly. The instrument governs the Minister and incorporates the standards NATA assesses. It does not name insurers. An insurer's leverage is the provider contract, the notification duty and the claims consequence of an accreditation lapse, not a duty in this instrument.
The authority is subsection 23DNA(1) of the Health Insurance Act 1973, which lets the Minister determine the principles applied in exercising the approval powers under section 23DN. The instrument does not name insurers, and it does not impose an obligation on them. The commercial link is real: Medicare benefits for pathology depend on the service being rendered by or on behalf of an approved pathology practitioner in an accredited laboratory operated by an approved pathology authority. An insurer that funds or contracts those services should check that the provider contract warrants accreditation against the standards in force, requires notification of a suspension or revocation, and records the claims consequence of a lapse.
Is there any insurer obligation in the text?
No. The instrument names the Minister, the independent body, the approved pathology authority and the practitioner. It does not name insurers.
What should an insurer ask for?
A warranty that the laboratory is accredited against the standards in force, a notification duty for a suspension or revocation, and the current scope.
Where this comes from
The register states each provision in our own words and cites the section or item. The dates page separates the two commencements. The official text is F2026L00927 on the Federal Register.
Not legal advice; does not certify. The standards themselves are separate documents and are not reproduced here.